fbpx

“A Degree Of Normalcy” Still Looms Distant — But Vaccines Could Get Us There

The COVID-19 pandemic may seem interminable, but there is an end in sight — it’s just not coming in the next few months, and it’s going to require us to put in the work. What is the work? It’s the same thing much of the nation — and the global population — has been doing all along, and that a subset of the populace simply refuses to do.

Brandon Rivera, a Los Angeles County emergency medical technician, gives a second does of Pfizer-BioNTech Covid-19 vaccine to Aaron Delgado, 16, at a pop up vaccine clinic in the Arleta neighborhood of Los Angeles, California, August 23, 2021. – The US Food and Drug Administration on August 23, fully approved the Pfizer-BioNTech Covid shot, triggering a new wave of vaccine mandates as the Delta variant batters the country.
Around 52 percent of the American population is fully vaccinated, but health authorities have hit a wall of vaccine hesitant people, impeding the national campaign. (Photo by Robyn Beck / AFP) (Photo by ROBYN BECK/AFP via Getty Images)

Dr. Anthony Fauci answered this question yet again this week, warning that winter months are always hard in terms of infectious disease, and that typical winter illnesses like the flu and other respiratory infections could further complicate things, but that if enough of the population gets vaccinated, we could see some normalcy by spring of 2022.

Of course, he can’t make any guarantees about the future, particularly about how the virus might continue to mutate, especially if it’s allowed to continue incubating and being passed around, but after a trying year-and-a-half of restrictions, fights to get people to submit to even the most basic of these restrictions, and watching loved ones die and health workers get burned out and exhausted, any glimmer of hope is welcome.

The Washington Post reported earlier this month that 70% of U.S. adults have received at least one shot, and about half of the population is fully vaccinated.

These numbers come before the first of three vaccines used in the U.S. (Pfizer) received full approval from the FDA, and with children under 12 still waiting for approval to be vaccinated against COVID-19.

If the other two vaccines (Johnson & Johnson and Moderna) receive their full approval and approval is also granted for vaccinating children, the door could be open for a much more vaccinated population in coming months.



Follow Us On: Facebook and Twitter